|1.||Vinarov, A Z: 4 articles (03/2012 - 01/2006)|
|2.||Aliaev, Iu G: 4 articles (03/2012 - 01/2006)|
|3.||Spivak, L G: 4 articles (03/2012 - 01/2006)|
|4.||Mazo, E B: 3 articles (11/2010 - 09/2001)|
|5.||Lokshin, K L: 3 articles (11/2010 - 01/2006)|
|6.||Demidko, Iu L: 2 articles (03/2012 - 11/2010)|
|7.||Permiakova, O V: 2 articles (11/2010 - 07/2009)|
|8.||Medvedev, A A: 2 articles (11/2010 - 07/2009)|
|9.||Shkol'nikov, M E: 2 articles (11/2010 - 07/2009)|
|10.||Apolikhin, O I: 2 articles (11/2010 - 07/2009)|
|1.||Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/01/2011 - "The study aimed to evaluate the long-term efficacy of treatment with extract of Serenoa repens (Prostamol Uno) in patients with lower urinary tract symptoms (LUTS) induced by benign prostatic hyperplasia (BPH). "
11/01/2010 - "[Results of three-year clinical study of prostamol uno efficacy and safety in patients with initial symptoms of prostatic adenoma and risk of its progression]."
07/01/2009 - "The article presents 2-year pilot results of a multicenter, randomized, controlled trial of prostamol-UNO effects on symptoms progression, quality of life, tolerance and safety in patients with early prostatic adenoma. "
07/01/2009 - "[Efficacy and safety of prostamol-UNO in the treatment of patients with initial symptoms of prostatic adenoma and risk of progression: 2 years of investigations]."
05/01/2007 - "[Expediency of switching from combined therapy with prostamol Uno and alpha-1-adrenoblockers to monotherapy with prostamol Uno in patients with prostatic adenoma]."
11/01/2011 - "Prostamol Uno, unlike Samprost, prevents the development of reduced sexual motivation, one of the complications of chronic prostatitis."
01/01/2006 - "Prostamol Uno showed good efficacy and safety profile in patients with category III prostatitis."
01/01/2006 - "[Efficiency and safety of prostamol-Uno in patients with chronic abacterial prostatitis]."
03/01/2012 - "Prostamol uno is effective for prevention of both recurrences of chronic prostatitis exacerbations and development of prostatic adenoma."
03/01/2012 - "The results of a retrospective study of efficacy of prostamol uno in a standard single dose of 320 mg/day in prevention of chronic prostatitis recurrences and prostatic adenoma used for 5 years as an adjuvant to standard therapy of chronic prostatitis exacerbations were compared with those of standard course antibacterial and anti-inflammatory treatment alone. "
11/01/2011 - "Comparative experimental evaluation of the efficacy of Prostamol Uno and Samprost on rat model of chronic aseptic prostate inflammation."
11/01/2011 - "Comparative experimental evaluation of the efficiency of prostatotropic drugs Prostamol Uno and Samprost on the model of the chronic aseptic prostate inflammation in rats was performed. "